Eurofins Scientific: 2016 Annual Report Notification
February 28 2017 - 12:30AM
Business Wire
Regulatory News:
Eurofins Scientific (Paris:ERF) announces that its 2016 Annual
Report is now available
onhttp://www.eurofins.com/investor-relations/reports-presentations/
Notes for the editor:
Eurofins – a global leader in bio-analysisEurofins
Scientific through its subsidiaries (hereinafter sometimes
“Eurofins” or “the Group”) believes it is the world leader in food,
environment and pharmaceutical products testing and that it is also
one of the global independent market leaders in certain testing and
laboratory services for agroscience, genomics, discovery
pharmacology and for supporting clinical studies. In addition,
Eurofins is one of the key emerging players in specialty clinical
diagnostic testing in Europe and the USA. With over 27,000 staff in
310 laboratories across 39 countries, Eurofins offers a portfolio
of over 130,000 analytical methods for evaluating the safety,
identity, composition, authenticity, origin and purity of
biological substances and products, as well as for innovative
clinical diagnostic. The Group objective is to provide its
customers with high-quality services, accurate results on time and
expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170227006090/en/
Eurofins ScientificInvestor RelationsPhone:
+32-2-769 1620E-mail: ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024